Carbetocin intranasal (Ferring Pharmaceuticals)
N/A
Report date: 2025/09/25 20:00:07
Base Information
Drug NameCarbetocin intranasal (Ferring Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesFerring Bv
China Registration ClassN/A
Develop Information
Active CompaniesAcadia Pharmaceuticals IncLevo Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A